Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
02/05/2014 | EP2692742A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect |
02/05/2014 | EP2692728A1 Novel furanone derivative |
02/05/2014 | EP2692724A1 Chiral 3-hydroxypyrid-4-one derivative, and synthesis and use thereof |
02/05/2014 | EP2692359A1 Potentiator of cancer immunity containing rankl antagonist |
02/05/2014 | EP2692358A1 Therapeutic agent for cancer, and method for determining prognosis of cancer |
02/05/2014 | EP2692353A2 Peptide LGD or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis |
02/05/2014 | EP2692348A1 Antitumor agent containing carbon dioxide as active ingredient |
02/05/2014 | EP2691526A1 Compositions and methods for treating, diagnosing and monitoring disease |
02/05/2014 | EP2691525A1 Treatment and prognosis of solid tumour cancers |
02/05/2014 | EP2691421A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
02/05/2014 | EP2691419A2 Antibodies directed against icos and uses thereof |
02/05/2014 | EP2691402A1 Bifunctional hydroxy-bisphosphonic acid derivatives |
02/05/2014 | EP2691395A1 Processes for preparing tofacitinib salts |
02/05/2014 | EP2691391A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases |
02/05/2014 | EP2691389A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
02/05/2014 | EP2691388A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
02/05/2014 | EP2691384A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases |
02/05/2014 | EP2691375A1 Substituted benzimidazoles |
02/05/2014 | EP2691155A2 Preparation of maytansinoid antibody conjugates by a one-step process |
02/05/2014 | EP2691120A2 Theranostic imaging agents and methods of use |
02/05/2014 | EP2691117A2 Process for manufacturing conjugates of improved homogeneity |
02/05/2014 | EP2691104A1 Ezatiostat for treating multiple myeloma |
02/05/2014 | CN103562386A REIC-expressing adenovirus vector |
02/05/2014 | CN103562226A Use of inhibitors of EGFR-family receptors in the treatment of hormone refractory breast cancers |
02/05/2014 | CN103562223A Anti c-Met antibodies |
02/05/2014 | CN103562220A 抗癌融合蛋白 Anticancer fusion protein |
02/05/2014 | CN103562212A Method for manufacturing phosphonocrotonic acid derivative |
02/05/2014 | CN103562210A Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
02/05/2014 | CN103562204A Aminopyrazine compounds useful as inhibitors of TRA kinase |
02/05/2014 | CN103562202A BCL-2/BCL-XL inhibitors and therapeutic methods using the same |
02/05/2014 | CN103562197A Solid forms of 3-(5-amino-2methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
02/05/2014 | CN103562186A Substituted benzoazepines as toll-like receptor modulators |
02/05/2014 | CN103562184A Pharmaceutically active disubstituted pyridine derivatives |
02/05/2014 | CN103561773A Theranostic imaging agents and methods of use |
02/05/2014 | CN103561772A Immunoconjugates, compositions containing them, and methods of making and use |
02/05/2014 | CN103561745A Medicaments and methods for treating cancer |
02/05/2014 | CN103561743A Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione |
02/05/2014 | CN103561734A Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck |
02/05/2014 | CN103561720A Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer |
02/05/2014 | CN103555765A Transcriptional regulation tumor targeting replicative oncolytic adenovirus vector, oncolytic adenovirus carrying therapy gene and preparation method and application thereof |
02/05/2014 | CN103555764A MUC1 (Mucins) and IL-2 double-gene coexpression recombinant vector as well as preparation method and application thereof |
02/05/2014 | CN103555763A IL-2 and MART-1 dual-gene co-expression recombinant vector as well as preparation method and application of recombinant vector |
02/05/2014 | CN103555762A AFP and GM-CSF dual-gene co-expression recombinant vector as well as preparation method and application of recombinant vector |
02/05/2014 | CN103555744A Nucleotide sequence and amino acid sequence of arenicola cristata protease gene with antineoplastic activity |
02/05/2014 | CN103555743A Cloning and expression of antineoplastic protease cDNA (complementary Deoxyribose Nucleic Acid) of arenicola cristata |
02/05/2014 | CN103555733A Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
02/05/2014 | CN103555731A Ser536 phosphorylated gene of NF-kB RelA/p65 and use thereof |
02/05/2014 | CN103555729A Modified TRAIL gene sequence, expression method and application |
02/05/2014 | CN103555725A Sdf-i binding nucleic acids |
02/05/2014 | CN103555722A Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna |
02/05/2014 | CN103555622A Bacillus marinus S-1 and anti-tumor active polypeptide produced thereby |
02/05/2014 | CN103554297A Preparation method and application of high-sulfation-degree radix hedysari polysaccharide sulfate |
02/05/2014 | CN103554290A Glabrous sarcandra herb acidic polysaccharide, preparation method and application thereof |
02/05/2014 | CN103554289A Rhizoma atractylodis sinensis polysaccharide and extraction method and applications thereof in preparing anti-tumor medicaments |
02/05/2014 | CN103554266A Tumstatin fusogenic peptide with anti-tumor effect, and preparation method and application thereof |
02/05/2014 | CN103554262A Anti-cyclooxygenase humanized single-chain antibody |
02/05/2014 | CN103554242A Liproteins, preparation method and application of liproteins in preparing medicament for preventing and treating tumor diseases |
02/05/2014 | CN103554222A Compounds for enzyme inhibition |
02/05/2014 | CN103554213A 4-oxa-androstane-3-ketone-17beta-amides derivatives, as well as preparation method and medical applications thereof |
02/05/2014 | CN103554210A Sterides 5 alpha-reductase inhibitor, as well as preparation method and medical application thereof |
02/05/2014 | CN103554204A Capecitabine direct-tabletting crystal as well as preparation method thereof and capecitabine direct tablet |
02/05/2014 | CN103554188A 6-(azacyclo-substitute) anthraquinone platinous chloride complex as well as preparation method and application thereof |
02/05/2014 | CN103554187A Platinum complexes, protein complexes prepared from same, and preparation method of protein complexes |
02/05/2014 | CN103554170A Aryl organic acid ester-containing tricyclohexyltin compounds, and preparation methods and application thereof |
02/05/2014 | CN103554143A Derivatives of 1-amino-2-cyclobutylethylboronic acid |
02/05/2014 | CN103554140A Preparation method and application of anthraquinone polypyridine ligand and binuclear ruthenium complexes |
02/05/2014 | CN103554135A Chromone structure containing isoxazole norcantharidin derivatives as well as preparation method and application thereof |
02/05/2014 | CN103554134A Chromone structure containing isoxazole norcantharidin derivatives as well as preparation method and application thereof |
02/05/2014 | CN103554124A Bioactive components in bamboo leaf green liquor and medical application thereof |
02/05/2014 | CN103554123A Chromone structure-containing pyrazole norcantharidin derivatives, and preparation method and application thereof |
02/05/2014 | CN103554122A Chromone structure-containing pyrazole norcantharidin derivative as well as preparation method and application thereof |
02/05/2014 | CN103554121A 3,3-spiro (2-tetrahydrofuranyl)-oxindole polycyclic compound and application thereof |
02/05/2014 | CN103554120A Preparation method of 3, 3-spiro (2-tetrahydrofuranyl)-oxindole polycyclic compound |
02/05/2014 | CN103554119A Preparation method of tetrahydrofuran benzodihydropyran polycyclic compound |
02/05/2014 | CN103554118A Tetrahydrofuran benzodihydropyran polycyclic compound and application thereof |
02/05/2014 | CN103554116A Molecularly targeted anti-cancer photosensitizer tamoxifen-phthalocyanine conjugate and preparation method thereof |
02/05/2014 | CN103554104A Azaindoles useful as inhibitors of jak and other protein kinases |
02/05/2014 | CN103554091A Quinazoline derivative as well as preparation method and use thereof |
02/05/2014 | CN103554086A Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
02/05/2014 | CN103554074A Preparation method of 3-trifluoromethyl coumarin derivative |
02/05/2014 | CN103554070A Ascorbic acid bismuth oxide, preparation method and application of ascorbic acid bismuth oxide |
02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity |
02/05/2014 | CN103554030A Novel forms of bendamustine free base |
02/05/2014 | CN103554008A 1,3-substituted-5-acetaminoindolone compounds and application thereof to anti-tumor drugs |
02/05/2014 | CN103554007A Novel 4,5-substituted-7-methyl formate indoledione derivatives and application thereof in anti-tumor drugs |
02/05/2014 | CN103553973A o-nitroaroyl beta-chloroethyl nitrosourea compounds, preparation and use thereof |
02/05/2014 | CN103553957A Colchicine derivative containing histone deacetylase inhibitory activity, preparation method and application thereof |
02/05/2014 | CN103553892A Diterpenoid compound as well as application thereof based on anti-tumor effect |
02/05/2014 | CN103553888A Honokiol derivative and preparation method and application thereof in preparation of antitumor drugs |
02/05/2014 | CN103550834A Embolism material composition as well as preparation method and use thereof |
02/05/2014 | CN103550796A Method for preparing iodine-125 sealed seed source core |
02/05/2014 | CN103550791A Preparation and application of water-soluble magnetic targeting carbon composite material |
02/05/2014 | CN103550789A Preparation and application of oral tumor vaccine with attenuated salmonella typhimurium as vector |
02/05/2014 | CN103550785A Novel use of TGF (Transforming Growth Facto)-beta receptor binding protein-1 |
02/05/2014 | CN103550777A Multi-drug self-aggregation composite nanoparticles as well as preparation method and application thereof |
02/05/2014 | CN103550776A Hydrophobic drug nanoparticles as well as preparation method and application thereof |
02/05/2014 | CN103550774A Method for screening sound-sensitive agent in induction of mitochondrial pathway apoptosis |
02/05/2014 | CN103550742A Traditional Chinese medicine for preventing postoperative metastasis of gastric cancer |
02/05/2014 | CN103550738A Preparation method and application of cortex moutan-cape jasmine fruit ease pill |
02/05/2014 | CN103550719A Traditional Chinese medicinal composition for treating nasopharyngeal carcinoma |